RxDoctor Payments Data

Parag Parikh, MD

Radiation Oncology · Detroit, MINPI 1528088929

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $10,743 of the $15,616 with a category attached, or 68.8%. Viewray Technologies Inc accounts for 96.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $11,914 and has fallen 98.4% since, to $186 in 2025. Among radiation oncology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,616in general payments, 2019–2025

Across 34 payments — averaging $459.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viewray Technologies Inc$15K
  • Siemens Medical Solutions USA, Inc.$281
  • Biocompatibles, Inc.$105
  • Philips North America LLC$73
  • AstraZeneca$43
  • Zap Surgical Systems, Inc.$33
$214,186in research payments, 2019–2025

Across 13 payments — averaging $16,476 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Viewray Technologies Inc$214K

What the payments were for

  • Consulting fees$2,20014%
  • Speaking & faculty fees$1,0006%
  • Travel & lodging$10,74369%
  • Food & beverage$1,67311%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viewray Technologies Inc28$15,081
Siemens Medical Solutions USA, Inc.2$281
Biocompatibles, Inc.1$105
Philips North America LLC1$73
AstraZeneca1$43
Zap Surgical Systems, Inc.1$33

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,616 in reported general payments places this provider in the 90th percentile of 198 radiation oncology providers in Michigan.

See all radiation oncology providers in Michigan

Medicare billing

Part B allowed, 2024
$152,000
Medicare patients
138
Services billed
1,281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron11$116

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →